FDA Inspection
ImpactLifeImpactLife – FDA Inspection, Aug 26, 2022
Record Details
This FDA Inspection record concerns ImpactLife, with an inspection on August 26, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- ImpactLife
- Inspection Date
- August 26, 2022
- Product Type
- Biologics
View Company Profile
ID · 6e7055e0-3337-47c1-999c-408097818f9b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1178326
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of ImpactLife
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 11, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 17, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 22, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 21, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for ImpactLife
- FDA Inspection 1022638 - 2017-07-11
- FDA Inspection 919931 - 2015-03-17
- FDA Inspection 828388 - 2013-04-22
- FDA Inspection 694631 - 2010-10-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.